Apogee Therapeutics APGE
NASDAQ APGE
$135.07 -0.01 (-0.01%)
At close: Sep 2, 2026 · 4:00 PM EDT

Apogee Therapeutics (APGE) Prepaid Assets (2022 - 2026)

Apogee Therapeutics (APGE) posted quarterly Prepaid Assets of $3.4 million for Q1 2026, up 474.57% year-over-year from $586000.0 in Q1 2025, and up 456.53% quarter-over-quarter from $605000.0 in Q4 2025.

Analysis

Apogee Therapeutics (APGE) Prepaid Assets (2022 - 2026) Analysis & Trends

Apogee Therapeutics (APGE) has reported Prepaid Assets for 5 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets rose 474.57% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 474.57% YoY), while the FY2025 annual figure was $605000.0, down 93.32% from the prior year.
  • Prepaid Assets rose to $3.4 million in Q1 2026 per APGE's latest filing, from $605000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $10.7 million in Q2 2025 and bottomed at $165000.0 in Q4 2022.
  • Historically, Prepaid Assets has averaged $4.0 million across 5 years, with a median of $3.4 million in 2026.
  • On a YoY basis, Prepaid Assets climbed as much as 1771.21% in 2025 and fell as far as 93.32% in 2025.
  • Apogee Therapeutics' Prepaid Assets stood at $165000.0 in 2022, then jumped by 1687.88% to $2.9 million in 2023, then surged by 207.12% to $9.1 million in 2024, then sank by 93.32% to $605000.0 in 2025, then surged by 456.53% to $3.4 million in 2026.
  • Business Quant data shows APGE's Prepaid Assets at $3.4 million in Q1 2026, $605000.0 in Q4 2025, and $7.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Apogee Therapeutics 10.18 Bn 9.20 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.81 Mn
Mar 31, 2026 13.91 Mn
Dec 31, 2025 11.17 Mn
Sep 30, 2025 12.81 Mn
Jun 30, 2025 10.70 Mn
Mar 31, 2025 8.20 Mn
Dec 31, 2024 9.06 Mn
Sep 30, 2024 8.43 Mn
Jun 30, 2024 5.63 Mn
Mar 31, 2024 4.41 Mn
Dec 31, 2023 2.95 Mn
Sep 30, 2023 3.57 Mn
Jun 30, 2023 5.60 Mn
Dec 31, 2022 165,000.00